Release Date: 13/12/12 14:45 Summary: Forthcoming release of shares from escrow Price Sensitive: No Download Document 280.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%